Laboratory Monitoring for Hospitalized Patients with Hyperkalemia and Acute-on-Chronic Renal Failure

Essential Laboratory Parameters to Monitor

Electrolyte abnormalities, including potassium, sodium, phosphate, magnesium, and calcium, must be closely monitored in patients with hyperkalemia and acute-on-chronic renal failure, as these disorders occur in up to 65% of such patients and are associated with increased mortality 1, 2
The American College of Cardiology recommends monitoring serum potassium every 6-12 hours in critically ill patients and those with acute hyperkalemia 2
Hyperkalemia (K+ >5.0 mmol/L) can cause life-threatening cardiac arrhythmias and sudden death, with a prevalence of up to 65% in critically ill patients 3, 4
The European Society of Cardiology recommends target potassium range of 4.0-5.0 mmol/L to prevent adverse cardiac effects 5
The Mayo Clinic recommends obtaining ECG immediately if potassium >6.0 mmol/L or if patient develops symptoms, though ECG changes are highly variable and not as sensitive as laboratory testing 4

The American College of Critical Care Medicine recommends monitoring electrolytes every 6-12 hours for critically ill patients with acute-on-chronic renal failure 2
More frequent monitoring (every 4-6 hours) is recommended if patient is on continuous kidney replacement therapy (CKRT) due to significant electrolyte shifts 2
The American Diabetes Association recommends glucose monitoring every 4-6 hours or more frequently if on insulin therapy 2

Pseudohyperkalemia must always be ruled out before aggressive treatment, which can result from hemolysis, repeated fist clenching, or poor phlebotomy technique, with a recommended repeat measurement with proper technique or obtain arterial sample 4
The European Heart Journal recommends reviewing all medications that can cause hyperkalemia, including RAASi drugs, potassium-sparing diuretics, NSAIDs, beta-blockers, trimethoprim-sulfamethoxazole, heparin, and calcineurin inhibitors 3
Combined electrolyte deficiencies, including hypomagnesemia and hypokalemia, significantly increase cardiac risk and must be corrected simultaneously 5